Infliximab in the therapy of rheumatoid arthritis

Infliximab in the therapy of rheumatoid arthritis

Objective. To assess efficacy and tolerability of infliximab in pts with rheumatoid arthritis (RA) in real clinical practice.Materials and methods. 75 RA pts with high disease activity according to DAS 28 in 80% who received previous antirheumatic drugs without proper effect were included in an open...

Full description

Bibliographic Details
Main Authors:	G. V. Lukina, Y. A. Sigidin, E. S. Posdnyakova, E. L. Luchihina, D. E. Karateev, E. L. Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2016-05-01
Series:	Научно-практическая ревматология
Subjects:	rheumatoid arthritis anticytokine therapy infliximab
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2189

Similar Items

Clinical experience with infliximab administration in patients with rheumatoid arthritis by Russian register data
by: Galina Viktorovna Lukina, et al.
Published: (2009-08-01)

EFFICACY OF INFLIXIMAB IN RHEUMATOID ARTHRITIS: A RELATIONSHIP TO THE TOTAL DOSE OF THE DRUG
by: E. S. Aronova, et al.
Published: (2015-10-01)

EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)
by: E.I. Alexeeva, et al.
Published: (2006-01-01)

PROMOTER POLYMORPHISM -857С>T OF TNFα GENE AND EFFICACY OF ANTICYTOKINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. N. Silkov, et al.
Published: (2014-07-01)

Infliximab tolerance in patients with rheumatoid arthritis in real clinical practice
by: E. S. Aronova, et al.
Published: (2020-02-01)

INFLIXIMAB (REMICADE): POSSIBILITIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: Nataliya Vladimirovna Chichasova, et al.
Published: (2011-03-01)

Russian registry of Infliximab.Impact of therapy on the functional status of patients with rheumatoid arthritis
by: V N Amirdzhanova, et al.
Published: (2010-12-01)

Development of Anti-bodies against Infliximab in Iraqi Patients with Rheumatoid Arthritis.
by: Mohammed A. Al-Karkhi, et al.
Published: (2015-10-01)

Effect of infliximab dose increase in rheumatoid arthritis at different trough concentrations: a cohort study in clinical practice conditions
by: Chamaida ePlasencia, et al.
Published: (2015-10-01)

GOUT – induced by Infliximab?- case report
by: Anca Chiriac, et al.
Published: (2012-10-01)

Combination therapy for rheumatoid arthritis with rituximab and leflunomide(preliminary results of the Russian ARBITR Registry)
by: Evgeniy L'vovich Nasonov, et al.
Published: (2011-02-01)

INFLIXIMAB-INDUCED LUPUS-LIKE SYNDROME IN A FEMALE PATIENT WITH RHEUMATOID ARTHRITIS (A CASE REPORT): AN ACCIDENT OR REGULARITY?
by: Yu. V. Muravyev, et al.
Published: (2017-09-01)

Evaluation of myocardial damage in different types of rheumatoid arthritisduring disease-modifying antirheumatic drug or biological therapy (with infliximab)
by: V I Mazurov, et al.
Published: (2010-12-01)

Comparison of Rheumatoid Arthritis Patients’ 2-Year Infliximab, Abatacept, and Tocilizumab Persistence Rates
by: Laetitia Diep, et al.
Published: (2022-10-01)

Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence
by: Iannone F, et al.
Published: (2022-06-01)

EFFECT OF INFLIXIMAB ON PARAMETERS OF REMODELING OF ARTERIAL BLOODSTREAM, RANKL AND OSTEOPROTEGERIN LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Larisa Aleksandrovna Knyazeva, et al.
Published: (2014-02-01)

Predicting the development of rheumatoid arthritis in patients with early undifferentiated arthritis
by: E L Luchihina, et al.
Published: (2009-04-01)

Intraarticular Injection of Infliximab-Loaded Thermosensitive Hydrogel Alleviates Pain and Protects Cartilage in Rheumatoid Arthritis
by: Chen W, et al.
Published: (2020-12-01)

The Impact of Early Optimization of Infliximab Blood Concentrations >1 μg/mL on Therapeutic Effectiveness in Rheumatoid Arthritis
by: Yuji Nozaki, et al.
Published: (2023-04-01)

Leflunomide (Arava) in early rheumatoid arthritis
by: R V Balabanova, et al.
Published: (2005-10-01)

COMPARATIVE EFFICIENCY AND TOLERABILITY OF CURRENT THERAPIES FOR EARLY RHEUMATOID ARTHRITIS
by: E. V. Fedorenko, et al.
Published: (2015-04-01)

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab
by: Ellis LA, et al.
Published: (2019-01-01)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
by: Proton Rahman, et al.
Published: (2020-09-01)

DYNAMICS OF CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS AS INFLUENCED BY INFLIXIMAB (REMIKEID) ADMINISTRATION
by: E. S. Zhugrova, et al.
Published: (2014-07-01)

Derlin-1, as a Potential Early Predictive Biomarker for Nonresponse to Infliximab Treatment in Rheumatoid Arthritis, Is Related to Autophagy
by: Yongsong Cai, et al.
Published: (2022-01-01)

The first experience of melatonin administration for correction of sleep disturbances in rheumatoid arthritis patients
by: A. E. Karateev, et al.
Published: (2004-08-01)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
by: van der Maas Aatke, et al.
Published: (2012-09-01)

THE EFFECT OF ABATACEPT ON BLOOD BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-09-01)

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy
by: Stanley B. Cohen, et al.
Published: (2018-07-01)

PULMONARY INVOLVEMENT IN RHEUMATOID ARTHRITIS
by: D. V. Bestaev, et al.
Published: (2014-09-01)

Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results
by: Nozaki Y, et al.
Published: (2018-11-01)

Gold preparations in therapy of rheumatoid and psoriatic arthritis
by: V A Nasonova, et al.
Published: (2003-05-01)

GUT MICROSYMBIOCENOSIS IN CHILDREN WITH REACTIVE ARTHRITIS
by: O. V. Bukharin, et al.
Published: (2016-12-01)

Cost-effectiveness Analysis of Reference Infliximab (Remicade) Compared to its Biosimilar (Remsima) in Iraqi Patients with Rheumatoid Arthritis (Conference Paper )#
by: Hasan Raid Fadhil, et al.
Published: (2023-02-01)

Biological treatment of gastrointestinal diseases
by: Leonid Borisovich Lazebnik, et al.
Published: (2011-02-01)

Safety and efficiency of therapy by gene-engineering-biological preparations of rheumatoid arthritis
by: E. A. Strel’tsov
Published: (2018-10-01)

Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study
by: Hua Ye, et al.
Published: (2023-03-01)

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
by: Clifton O. Bingham, et al.
Published: (2023-02-01)

Pharmacotherapy for rheumatoid arthritis in the early 21st century: Russian and international experience
by: E L Nasonov, et al.
Published: (2013-08-01)

Diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis
by: D V Bestaev, et al.
Published: (2013-05-01)